Abstract
The aim of this study was to investigate the association of stellate cell activation with serum fibrosis markers in a rat model of hepatic fibrosis prepared using a choline-deficient l-amino acid (CDAA) defined diet. CDAA diet administration resulted in increased liver hydroxyproline contents in a time-dependent manner with activated stellate cells, expressing α-smooth muscle actin (α-SMA) as well as increased serum concentrations of amino-terminal procollagen type III peptide (PIIIP) and the 7S fragment of type IV collagen. Hydroxyproline content of the liver showed a closer correlation with the serum 7S (r = 0.75, P < 0.01) concentration than with the serum PIIIP (r = 0.51, P < 0.01) concentration. The percent area of α-SMA-positive cells showed stronger correlation with the serum PIIIP concentration (r = 0.85, P < 0.01) than with the 7S concentration (r = 0.50, P < 0.01). These results indicate that the serum PIIIP concentration reflects the activity of fibrogenesis, while the serum 7S concentration reflects the accumulation of collagen fibers in the liver.
Similar content being viewed by others
REFERENCES
Tanikawa K: Serum marker for hepatic fibrosis and related liver pathology. Pathol Res Pract 190:960-968, 1989
Roche H, Vergas L, Hahn E, Kalbfeisch H, Bruguera M, Timpl R: Radioimmunoassay for type III collagen peptide and its application to human liver disease. Eur J Clin Invest 9:451-459, 1979
Risteli L, Risteli J: Noninvasive methods for detection of organ fibrosis. In Focus on Connective Tissue in Health and Disease. M Rojkind (ed). Boca Raton, Florida, CRC Press, 1990, pp 61-98
Gabrielli GB, Corrocher R: Hepatic fibrosis and its serum markers: A review. Dig Dis 9:303-316, 1991
Plebani M, Rurlina A: Biochemical markers of hepatic fibrosis. Clin Biochem 24:219-239, 1991
Niemela O, Risteli L, Salaniemi EA, Risteli J: Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest 15:132-137, 1985
Friedman SL: The cellular basis of hepatic fibrosis. N Engl J Med 328:1828-1835, 1993
Burt AD, Le Bail B, Balabaud C: Morphologic investigation of sinusoidal cells. Semin Liver Dis 13:21-38, 1993
Takamatsu S, Nakabayashi H, Okamoto Y, Nakano H: Non-invasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables. J Gastroenterol 32:355-360, 1997
Guechot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R: Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatology 20:388-393, 1994
Gerling B, Becker M, Waldschmidt J, Rehmann M, Schuppan D: Elevated serum aminoterminal procollagen type III peptide parallels collagen accumulation in rats with secondary biliary fibrosis. J Hepatol 25:79-84, 1996
Murawaki M, Ikuta Y, Nishimura Y, Koda M, Kawashaski H: Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis. J Hepatol 23:145-152, 1995
McCullough AJ, Stanssen WN, Wiesner RH, Czaja AJ: Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity. Hepatology 7:49-54, 1987
Surrenti C, Casini A, Milani S, Ambu S, Ceccatelli P, D'Agata A: Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis? Dig Dis Sci 32:705-709, 1987
Annoni G, Colombo M, Cantaluppi MC, Khlat B, Lampertico P, Rojkind M: Serum type III procollagen peptide and laminin (lam-P1) detect alcoholic hepatitis in chronic alcoholic abusers. Hepatology 9:693-697, 1989
Fukutomi T, Sakamoto S, Isobe H, Sakai H, Masumoto A, Nawata H: Clinical significance of serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 7:596-601, 1992
Yamada S, Suou T, Kawasaki H, Yoshikawa N: Clinical significance of serum 7S collagen levels in various liver diseases. Clin Biochem 25:467-470, 1992
Sakaida I, Kubota M, kayano K, Takenaka K, Mori K, Okita K: Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis 15:2201-2206, 1994
Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K: The prolyl 4-hydeoxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline deficient L-amino aciddefined diet. Hepatology 23:755-763, 1996
Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K: Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 28:298-306, 1996
Junquiera LCU, Bignolas G, Brentani RR: Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11:447-455, 1979
Kivirikko KI, Laitinen O, Prockop DJ: Modifications of specific assay for hydroxyproline in urine. Anal Biochem 19:249-255, 1967
Inayama S, Shibata T, Ohtsuki J, Saito S: A new microanalytical method for determination of hydroxyproline in connective tissue. Keio J Med 27:43-46, 1978
Sweat F, Puchtler H, Rosenthal SI: Sirius red F3BA as a stain for connective tissue. Arch Pathol 78:69-72, 1964
Nakabayashi H, Takamatsu S, Nakano H: A simple estimation of liver collagen content by the computed color image analyzer using Sirius red stained sections. Kanzo 34:212-218, 1993
Pilette C, Rousselet MC, Bedossa P, Chappard D, Oberti F, Rifflet H, Maiga MY, Gallois Y, Cales P: Histopathological evaluation of liver fibrosis: Quantitative image analysis vs semiquantitative scores Comparison with serum markers. J Hepatol 28:439-446, 1998
Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombari R, Mezzelani P, Corrocher R, De Sandre G: _-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol 18:112-118, 1993
Timple R, Wiedemann H, van Delden V, Furthmayr H, Kuhn K: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 120:203-211, 1981
Misaki M, Shima T, Yano Y, Sumita Y, Kano U, Murata T, Watanabe S, Suzuki S: Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Clin Chem 36:522-524, 1990
Timpl R, Glanville RW: The aminopropeptide of collagen. Clin Orthop Relat Res 158:224-242, 1981
Weiner FR, Giambrone MA, Czaja MJ, Shah A, Annoni G, Takahashi S, Eghbali M, Zern MA: Ito-cell gene expression and collagen regulation. Hepatology 11:111-117, 1990
Friedman SL, Roll FJ, Boyles J, Bissell DM: Hepatic lipocytes: The principal collagen producting cells of normal rat liver. Proc Natl Acad Sci USA 82:8681-8685, 1985
Clement B, Emonard H, Rissel M, Druguet M, Grimaud JA, Herbage D, Bourel M, Guillouzo A: Cellular origin of collagen and fibronectin in the liver. Cell Mol Biol 30:486-496, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hironaka, K., Sakaida, I., Uchida, K. et al. Correlation Between Stellate Cell Activation and Serum Fibrosis Markers in Choline-Deficient l-Amino Acid-Defined Diet-Induced Rat Liver Fibrosis. Dig Dis Sci 45, 1935–1943 (2000). https://doi.org/10.1023/A:1005556328028
Issue Date:
DOI: https://doi.org/10.1023/A:1005556328028